Cargando…
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma
Histone H3 mutations at amino acids 27 (H3K27M) and 34 (H3G34R) are recurrent drivers of pediatric-type high-grade glioma (pHGG). H3K27M mutations lead to global disruption of H3K27me3 through dominant negative PRC2 inhibition, while H3G34R mutations lead to local losses of H3K36me3 through inhibiti...
Autores principales: | Siddaway, Robert, Canty, Laura, Pajovic, Sanja, Milos, Scott, Coyaud, Etienne, Sbergio, Stefanie-Grace, Vadivel Anguraj, Arun Kumaran, Lubanszky, Evan, Yun, Hwa Young, Portante, Alessia, Carette, Sheyenne, Zhang, Cunjie, Moran, Michael F., Raught, Brian, Campos, Eric I., Hawkins, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547787/ https://www.ncbi.nlm.nih.gov/pubmed/36070144 http://dx.doi.org/10.1007/s00401-022-02489-2 |
Ejemplares similares
-
DIPG-14. PROTEOGENOMICS PROFILING REVEALS ENRICHED NON-HISTONE PROTEIN METHYLTRANSFERASES AS NEW THERAPEUTIC TARGETS IN DIPG
por: Anguraj Vadivel, Arun Kumaran, et al.
Publicado: (2023) -
Splicing is an alternate oncogenic pathway activation mechanism in glioma
por: Siddaway, Robert, et al.
Publicado: (2022) -
The in vivo Interaction Landscape of Histones H3.1 and H3.3
por: Siddaway, Robert, et al.
Publicado: (2022) -
Oncohistones: drivers of pediatric cancers
por: Mohammad, Faizaan, et al.
Publicado: (2017) -
The expanding landscape of ‘oncohistone’ mutations in human cancers
por: Nacev, Benjamin A., et al.
Publicado: (2019)